369 related articles for article (PubMed ID: 32643143)
1. Invited Review - Understanding cause and effect in Alzheimer's pathophysiology: Implications for clinical trials.
Boche D; Nicoll JAR
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):623-640. PubMed ID: 32643143
[TBL] [Abstract][Full Text] [Related]
2. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
3. Pathological changes induced by Alzheimer's brain inoculation in amyloid-beta plaque-bearing mice.
Lam S; Hérard AS; Boluda S; Petit F; Eddarkaoui S; Cambon K; ; Picq JL; Buée L; Duyckaerts C; Haïk S; Dhenain M
Acta Neuropathol Commun; 2022 Aug; 10(1):112. PubMed ID: 35974399
[TBL] [Abstract][Full Text] [Related]
4. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
[TBL] [Abstract][Full Text] [Related]
5. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease.
Paquet C; Amin J; Mouton-Liger F; Nasser M; Love S; Gray F; Pickering RM; Nicoll JA; Holmes C; Hugon J; Boche D
J Pathol; 2015 Apr; 235(5):721-30. PubMed ID: 25430817
[TBL] [Abstract][Full Text] [Related]
6. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
[TBL] [Abstract][Full Text] [Related]
7. Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.
Perez-Nievas BG; Stein TD; Tai HC; Dols-Icardo O; Scotton TC; Barroeta-Espar I; Fernandez-Carballo L; de Munain EL; Perez J; Marquie M; Serrano-Pozo A; Frosch MP; Lowe V; Parisi JE; Petersen RC; Ikonomovic MD; López OL; Klunk W; Hyman BT; Gómez-Isla T
Brain; 2013 Aug; 136(Pt 8):2510-26. PubMed ID: 23824488
[TBL] [Abstract][Full Text] [Related]
8. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β-independent regulators of tau pathology in Alzheimer disease.
van der Kant R; Goldstein LSB; Ossenkoppele R
Nat Rev Neurosci; 2020 Jan; 21(1):21-35. PubMed ID: 31780819
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
11. Roles of Microglia in AD Pathology.
Rong G; Hongrong W; Qingqi L; Jianfeng Z
Curr Alzheimer Res; 2023; 19(13):854-869. PubMed ID: 36740796
[TBL] [Abstract][Full Text] [Related]
12. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
13. Microglia in Alzheimer's Disease.
Süß P; Schlachetzki JCM
Curr Alzheimer Res; 2020; 17(1):29-43. PubMed ID: 32048973
[TBL] [Abstract][Full Text] [Related]
14. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
15. Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.
Streit WJ; Rotter J; Winter K; Müller W; Khoshbouei H; Bechmann I
J Alzheimers Dis; 2022; 85(4):1701-1720. PubMed ID: 34958037
[TBL] [Abstract][Full Text] [Related]
16. [Pathological changes induced by amyloid-β in Alzheimer's disease].
Takata K; Kitamura Y; Taniguchi T
Yakugaku Zasshi; 2011 Jan; 131(1):3-11. PubMed ID: 21212607
[TBL] [Abstract][Full Text] [Related]
17. Progression of neurofibrillary changes and PHF-tau in end-stage Alzheimer's disease is different from plaque and cortical microglial pathology.
Thal DR; Arendt T; Waldmann G; Holzer M; Zedlick D; Rüb U; Schober R
Neurobiol Aging; 1998; 19(6):517-25. PubMed ID: 10192210
[TBL] [Abstract][Full Text] [Related]
18. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease.
Takahashi RH; Nagao T; Gouras GK
Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941
[TBL] [Abstract][Full Text] [Related]
19. Invited Review: APOE at the interface of inflammation, neurodegeneration and pathological protein spread in Alzheimer's disease.
Tzioras M; Davies C; Newman A; Jackson R; Spires-Jones T
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):327-346. PubMed ID: 30394574
[TBL] [Abstract][Full Text] [Related]
20. Trem2 Deletion Reduces Late-Stage Amyloid Plaque Accumulation, Elevates the Aβ42:Aβ40 Ratio, and Exacerbates Axonal Dystrophy and Dendritic Spine Loss in the PS2APP Alzheimer's Mouse Model.
Meilandt WJ; Ngu H; Gogineni A; Lalehzadeh G; Lee SH; Srinivasan K; Imperio J; Wu T; Weber M; Kruse AJ; Stark KL; Chan P; Kwong M; Modrusan Z; Friedman BA; Elstrott J; Foreman O; Easton A; Sheng M; Hansen DV
J Neurosci; 2020 Feb; 40(9):1956-1974. PubMed ID: 31980586
[No Abstract] [Full Text] [Related]
[Next] [New Search]
